Trade names from 'clonidine' to 'co-trimoxazole' - Electronic medicinal guide TALKDRUGS

Solution for intravenousMr.aboutgabout the introduction of 0,1 mg / ml in ampoules but 1 ml.

The tablets covered with a cover of 25 mg.

Tablets, 5 mg + 0.625 mg + 2 mg, 5 mg + 1.25 mg + 4 mg, 5 mg + 2.5 mg + 8 mg, 10 mg + 1.25 mg + 4 mg, 10 mg + 2.5 mg + 8 mg.

Tablets, film-coated, 80 mg + 12.5 mg, 160 mg + 12.5 mg, 160 mg + 25 mg, 320 mg + 12.5 mg and 320 mg + 25 mg.

Novartis Pharma AG Switzerland
Tablets, film-coated, 80 mg + 12.5 mg, 160 mg + 12.5 mg.
Novartis Pharma AG Switzerland
Tablets, film-coated, 160 mg + 25 mg.
Novartis Pharma AG Switzerland
Tablets 10 mg + 12.5 mg. Tablets 20 mg + 12.5 mg.



Tablets of 0.625 mg + 2 mg and 1.25 mg + 4 mg.

ATOLL, LLC Russia

Tablets, 0.625 mg + 2 mg, 1.25 mg + 4 mg and 2.5 mg + 8 mg.

Tablets, 2 mg + 0.625 mg and 4 mg + 1.25 mg .
Tablets, film-coated, 150 + 12.5 mg, 150 + 25 mg, 300 + 12.5 mg, 300 + 25 mg.
Novartis Pharma AG Switzerland
Tablets 12.5 mg + 20 mg.


Suspension for oral administration of 240 mg / 5ml in dark glass bottles of 50, 100 and 125 g. Each vial with instructions for use and

Tablets 480 mg. 10 tablets in a planar cell package.

1 or 2 packs with instructions for use in a pack of cardboard.

Tablets 120 mg and 480 mg. 20 tablets in a jar of orange glass or in a jar of polymer type BP.10 tablets in a contiguous,
Tablets 120 mg and 480 mg. For 10 or 20 tablets in a planar cell pack. 1 or 2 contour squares with instructions
For 10 tablets in a planar cell package or a contiguous, cell-free package. For 20 tablets in a can of polymer or bottles